Graftys Closes €2 Million Investment Round

Graftys completed an investment round of €2 million (~US $2.03 million) with its existing shareholders. The company conceives, develops and commercializes injectable biomaterials in more than 25 countries.

Graftys is developing new generations of products for market launch in 2023 and 2024.

With the acquisition of Biologics4Life in...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us